Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - spesolimab - Ψωρίαση - Ανοσοκατασταλτικά - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.